IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomarin Pharmaceutical Inc

Q4 2016 vs Q1 2017

Comparing institutional holders between quarters

Quarters

Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Baker Bros. Advisors LP
UNCHANGED
Shares22,379,000 from 22,379,000
Change0 (0%)
Value$96.0K (+$5.4K)
Filed 2017-05-15
UBS Group AG
UNCHANGED
Shares21,000 from 21,000
Change0 (0%)
Value$90 (+$5)
Filed 2017-11-14
Bank of America Corp
UNCHANGED
Shares8,000 from 8,000
Change0 (0%)
Value$34 (+$2)
Filed 2017-05-15
Steward Partners Investment Advisory, LLC
NEW
Shares5,000
Change+5,000
Value$21
Filed 2017-11-22
Royal Bank of Canada
UNCHANGED
Shares2,000 from 2,000
Change0 (0%)
Value$9 ($0)
Filed 2017-05-15
Bank of Montreal
UNCHANGED
Shares1,000 from 1,000
Change0 (0%)
Value$4 ($0)
Filed 2017-04-11
Wells Fargo & Company
UNCHANGED
Shares1,000 from 1,000
Change0 (0%)
Value$4 ($0)
Filed 2017-04-28
Status
Baker Bros. Advisors LP
UNCHANGED22,379,00022,379,00000%$90.5K$96.0K+$5.4K2017-05-15
UBS Group AG
UNCHANGED21,00021,00000%$85$90+$52017-11-14
Bank of America Corp
UNCHANGED8,0008,00000%$32$34+$22017-05-15
Steward Partners Investment Advisory, LLC
NEW5,000—+5,000——$21—2017-11-22
Royal Bank of Canada
UNCHANGED2,0002,00000%$9$9$02017-05-15
Bank of Montreal
UNCHANGED1,0001,00000%$4$4$02017-04-11
Wells Fargo & Company
UNCHANGED1,0001,00000%$4$4$02017-04-28
Showing 7 of 7 institutions